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LETTERS TO THE EDITOR 
Renovascular Disease in the Elderly 
I believe that Olin et al. (1) may have misinterpreted the conclu•
sions of the ~tudy performed in our institution and published in 
1980 (2). and I would therefore appreciate the opportunity to restate 
our position on this ~ubJect. 
Olin et al. state: "Some investigators (quoting our study [2]) 
~uggest that blood pressure control after renal revascularization is 
dIrectly related to the age of the patient at the time of operation 
and therefore contend that renovascular surgery should be limited 
to patients under 50 to 55 years because the chance of curing 
hyperten~ion is small and the mortality rate is high." 
Although we found in our study (2) that older patients had a 
poorer blood pressure response, we did state that "we would still 
recommend, if other intra-abdominal surgery is required, that con•
comitant renova~cular reconstruction be performed for preservation 
of renal function and possible improvement of hypertension. Sim•
ilarly, in older patients with severe uncontrollable hypertension 
and a high grade renal artery stenosis, operation may be justified 
de~pite the greater risk of a poor response. " 
The principal reason for our recommendation against surgery, 
unless there were pressing indications, was neither the surgical 
risk (which wa~ 0% for i~olated renal surgery in our older group 
of patient~) nor the less favorable blood pressure response in the 
elderly. Rather, it was the fact that even in older patients in whom 
good blood pressure control was achieved, when hypertension had 
been chrome, long-term patient survival rates did not appear to be 
altered by succe~sful surgery. This is graphically shown in our 
FIgure 2 (2), where the survival curves for postoperative normo•
ten~ive subjects over 50 years of age and postoperative patients 
with ~evere hypertension over 50 years of age were almost 
~uperimposable . 
In the 21 patients treated surgically in the report of Olin et ai., 
the operative mortality was 4%. The short-term cure rate was 
quoted to be 25% WIth an improved rate of 65%. As shown in our 
study, the longer-term rates tend to be less satisfactory and, with 
time, an approximately 30% deterioration in the cured/improved 
rate can be expected. 
The comparison between the medical and surgical groups (I) 
~hould also be viewed the some caution. Although in Table 1 (1) 
the target organ mvolvement is listed as not statistically signifi•
cantly different among the groups, Table 5 shows that four of six 
patients in the medical mortality group but none in the surgical 
group had had a previous myocardial infarction. Furthermore, the 
three patients in the medical mortality group who had had cardiac 
catheterization all showed severe disease, whereas in two of the 
four in the surgical group who had catheterization there was mild 
disease. Clearly, in a retrospective study of this type some selection 
factors must have played a role in choosing the therapy. 
The principal reason for treating hypertension surgically is that 
pallents WIth ~Ignificant hypertension are prone to premature mor•
tality from ischemic heart disease, stroke or renal insufficiency. I 
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believe that a comparison of the data presented by Olin et al. (1) 
with the large number of patients we followed up to 25 years after 
operation shows that their study fails to demonstrate any benefit 
in regard to survival or reduction in morbidity in their older pop•
ulation. We would certainly concur that patients who are under 
poor medical control should be offered surgery if this appears 
feasible. However, we would caution against performing reno•
vascular surgery in elderly patients simply to improve blood pres•
sure recordings in the absence of any evidence that many of these 
patients will not continue to experience excessive mortality from 
pre-existing atherosclerotic lesions. 
We agree with the authors' recommendation that if hypertension 
is resistant to medical therapy, or a patient experiences undesirable 
side effects from medication or if renal function is jeopardized, 
surgical therapy should be considered. Nonetheless, there is a 
substantial preponderance of evidence in larger groups of patients 
suggesting that the outcome in the elderly is likely to be less 
favorable in terms of both relief of hypertension and significant 
impact on truly late mortality rates. Therefore, it would seem that 
one should continue to exercise a greater degree of selectivity in 
the choice of the patient who is to undergo renovascular surgery 
in this age group. 
GERALD M. LAWRIE, MD, FACC 
Professor of Surgery 
Baylor College of Medicine 
6535 Fannin Street 
Houston, Texas 77030 
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Reply 
Although there are similarities between our report and the earlier 
excellent report of Lawrie et ai., several significant differences 
must also be noted. 
Both reports are retrospective studies and some selection factors 
did play a role in choosing therapy in both series. The surgical 
mortality rate for isolated renal surgery was 0% in both series. 
The one perioperative death in our series (4%) occurred in a patient 
who had undergone resection of an abdominal aneurysm and renal 
revascularization. In the series of Lawrie and colleagues, the peri•
operative mortality rate was 4.8% when an associated vascular 
procedure was performed at the time of renal revascularization. 
Lawrie and colleagues considered surgery for patients with severe 
hypertension unresponsive to or poorly controlled with medical 
therapy. In our series, surgery or percutaneous transluminal an•
gioplasty was considered for patients with poorly controlled blood 
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pressure despite maximal antihypertensive therapy or intolerance 
to medications and also for preservation of renal function in pa•
tients with severe bilateral stenosis or high grade stenosis to a 
,olitary kidney. 
The differences in these reports must also be noted. In our 
series, all patients were 65 years of age or older, with a mean age 
Df 69 years as compared with a mean age of 50 years in the series 
reported by Lawrie et al. Forty-nine (98%) of 50 patients in our 
series had atherosclerotic renovascular disease as compared with 
Dnly 53% in their series. Our mean follow-up time of 18 months 
is considerably less than that of Lawrie et al. (49 months). 
We certainly agree that observed late mortality is due largely 
to myocardial infarction, stroke or renal failure. In the series of 
Lawrie et aI., 66% of surgically treated patients died of these 
~auses. In our surgical group, these causes were not associated. 
It is of particular interest, however, that four of the six late deaths 
in our medical group were secondary to complications of athero•
sclerosis. Furthermore, renal function deteriorated m nine patients 
in the medical group during the follow-up period with five having 
advanced chronic renal failure (one on dialysis). Renal function 
was stable or improved in six of eight patients who underwent 
angioplasty. We have long contended that careful attention to 
significant coronary or carotid lesions, or both, before renal re•
vascularization reduces perioperative morbidity and mortality in 
this group and should have a beneficial effect on late mortality 
from these observed atherosclerotic complications. 
Recent reports from the Cleveland Clinic (I) have focused on 
the beneficial effects of this approach on operative mortahty in 
100 consecutive patients (mean age 56 years) with atherosclerotic 
renovascular disease. Follow-up of these patients (2) has dem•
Dnstrated that the 5 year survival for the overall group is 91 o/c and 
is equivalent to the expected survival for a normal population of 
comparable age and sex distribution. These data are in contrast to 
the dramatic reduction in late survival in the patients of Lawrie et 
al. operated on when 50 years of age or older. 
Despite differences in these reports, the clear message to the 
reader is that interventive therapy in older patients with generalized 
atherosclerotic renovascular disease should be reserved for patients 
who are resistant to or intolerant of medical therapy or whose renal 
function is jeopardized. In addition, current data suggest that care•
ful attention to other atherosclerotic complications preceding renal 
revascularization minimizes operative mortality and may prolong 
mrvival and improve quality of life. 
JEFFREY W. OLIN, DO 
DONALD G. VIDT, MD, FACC 
RAY W. GIFFORD, JR., MD, FACC 
ANDREW C. NOVICK, MD 
rhe Cleveland Clinic Foundation 
9500 Euclid Avenue 
Cleveland. OhIO 44106 
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On the Occasion of the Two Hundredth 
Anniversary of Publication of "An Account 
of the Foxglove" by William Withering 
Bicentenniary of An Account of the Foxglove was celebrated on 
both sides of the Atlantic. 
The American College of Cardiology commemorated this oc•
casion with a symposium at its Annual Scientific Session held in 
March at Anaheim and with a supplement to its Journal which 
mcluded the papers presented at the meeting and invited contri•
butions (I). 
Our colleagues from Great Britain and Ireland held a joint 
meeting in Birmingham, home of William Withering. The chair•
man of the meetmg was Sir Raymond Hoffenberg, PRCP, William 
Withering Professor of Medicine at the University of Birmingham. 
The sessional chairmen were Michael Oliver, Sir Melville Amott 
and Howard Burchell, and Sir Raymond, who presided over the 
final scientific session, the William Withering Lecture of the Royal 
College of Physicians, which was delivered by Colin Dollery. 
Speakers in the scientific sessions were Thomas Smith, Denis 
Noble, Victor Perry, Dennis Krikler, William Littler, Frits Meijler, 
Abe Guz and Derek Gibson. Presentations by Drs. Dollery and 
Whitfield along with abstracts of the papers presented by the other 
partiCipants and a series of papers dealing with digitalis appeared 
m the September 1985 issue of the British Heart Journal (2). 
After the scientific proceedings, participants gathered at Edg•
baston Parish Church, in whose yard Withering is buried, for an 
address by George Whitfield and an orchestral recital. This was 
followed by a reception at Edgbaston Hall, Withering's old home, 
on whose ground the foxglove still grows. 
CHARLES FISCH, MD, FACC 
Indiana UllIversity MediCal Center 
1/00 West Michigan Street 
Indtanapolts. Indiana 46223 
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